共 14 条
- [1] Inhibition and induction of human cytochrome P450 enzymes: current status[J] . Olavi Pelkonen,Miia Turpeinen,Jukka Hakkola,Paavo Honkakoski,Janne Hukkanen,Hannu Raunio.Archives of Toxicology . 2008 (10)
- [3] Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms[J] . Arzu Gunes,Marja-Liisa Dahl.Pharmacogenomics . 2008 (5)
- [4] Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course[J] . Yue,Jiang,Miksys,Sharon,Hoffmann,Ewa,Tyndale,Rachel F.Journal of Psychiatry & Neuroscience : JPN . 2008 (1)
- [5] Drugs as CYP3A Probes, Inducers, and Inhibitors[J] . Yi-Tong Liu,Hai-Ping Hao,Chang-Xiao Liu,Guang-Ji Wang,Hong-Guang Xie.Drug Metabolism Reviews . 2007 (4)
- [6] Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction[J] . Martignoni,Groothuis,de Kanter.Expert Opinion on Drug Metabolism & Toxicology . 2006 (6)
- [7] CLINICAL AND TOXICOLOGICAL RELEVANCE OF CYP2C9: Drug-Drug Interactions and Pharmacogenetics[J] . Allan E. Rettie,Jeffrey P. Jones.Annual Review of Pharmacology and Toxicology . 2005
- [10] Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry[J] . Ulrich M. Zanger,Sebastian Raimundo,Michel Eichelbaum.Naunyn - Schmiedeberg’s Archives of Pharmacology . 2004 (1)